Plus Therapeutics Files Proxy Materials
Ticker: PSTV · Form: DEFA14A · Filed: May 1, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | DEFA14A |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, company-update
TL;DR
PLUS proxy filing dropped, governance matters ahead.
AI Summary
Plus Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on May 1, 2025. The company, formerly known as Cytori Therapeutics, Inc. and Macropore Inc., is based in Austin, TX, and operates in the surgical and medical instruments sector. This filing is related to the company's proxy materials.
Why It Matters
This filing indicates that Plus Therapeutics is proceeding with corporate governance matters, which could involve shareholder votes on important company decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently present new risks.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
- 0000950170-25-061484.txt (document) — Filing document name
- 20250501 (date) — Filing date
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement filed by Plus Therapeutics, Inc. with the SEC.
When was this filing submitted?
The filing was submitted on May 1, 2025.
What is the company's primary business sector?
Plus Therapeutics, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, with SIC code 3841.
Has the company operated under different names previously?
Yes, the company was formerly known as CYTORI THERAPEUTICS, INC. (name change effective 20050712) and MACROPORE INC (name change effective 20010320).
Where is Plus Therapeutics, Inc. located?
The company's business and mailing address is 4200 MARATHON BLVD., SUITE 200, AUSTIN, TX 78756.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 1, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).